In the background, a quieter but even costlier trend has been unfolding: the steady march upward of specialty drug costs for chronic conditions like rheumatoid arthritis, Crohns disease, and ulcerative colitis
Novo Nordisk, the maker of Wegovy, is surprised and disappointed by state officials decision to restrict GLP-1 coverage for MassHealth members, spokesperson David McAlpine said
There is an active debate about whether rapamycin and other rapalogs can extend human healthspan and lifespan
everyday-5-alcar-athletic-performance
It says: Medsafe has had a good response from NZ-based websites removing these products from their sites. While researching peptides over the last month, I have witnessed some of these websites being taken down in real time
in a U2OS cell line (cancer-derived cell line) [29] and in breast cancer cells [30, 31]